It has been reported that constitutive activity of ERK1/2 triggers increased EZH2 expression and global H3K27me3 levels in BRAFV600 melanoma cells (Yu et al., 2017; Grigore et al., 2020; Gebhardt et al., 2021). The gene discussed is EZH2; the disease is melanoma.